Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Tirzepatide Shortage Resolution and Its Impact The FDA officially resolved the tirzepatide injection shortage in October 2025, following Eli Lilly's expansion of manufacturing capacity at its new $2.5 billion facility in Lebanon, Indiana [3]
Another major drawback of drug-mediated weight loss is that individuals tend to regain weight once they stop taking the medication
Some clinicians overlap the medications briefly during the transition, continuing phentermine while semaglutide titrates up, then discontinuing phentermine once semaglutide reaches therapeutic levels
Langeskov EK, Kristensen K
To improve comfort and avoid skin issues Choosing the correct site makes it easier to manage pain and prevent problems like: Lipohypertrophy (fatty tissue buildup from repeated injections in the same area as explained by Cleveland Clinic) Bruising Irritation of nerves or blood vessels This is why moving between different injection spots matters
